MultiPlan Revises FY23 Sales Guidance To $950M-$980M From Prior Range Of $925M-$975M Vs. Consensus Of $946.8M; Expects Adjusted EBITDA Of $615M-$635M Up From Previous Outlook Of $600M-$650M
Portfolio Pulse from Benzinga Newsdesk
MultiPlan has revised its FY23 sales guidance to a range of $950M-$980M, up from the previous range of $925M-$975M. The consensus estimate was $946.8M. The company also expects its adjusted EBITDA to be between $615M-$635M, a slight adjustment from the previous outlook of $600M-$650M.
August 04, 2023 | 10:46 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
MultiPlan's revised FY23 sales guidance is above the consensus estimate, which could positively impact the company's stock. The adjusted EBITDA outlook is also revised, although the range is narrower.
The revised sales guidance is above the consensus estimate, which could be seen as a positive signal by the market, potentially leading to an increase in the stock price. The adjusted EBITDA outlook is also revised, but the range is narrower, which might indicate a more certain outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100